Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1143420210140080413
Public Health Weekly Report
2021 Volume.14 No. 8 p.413 ~ p.420
Epidemiology of Carbapenem-resistant Enterobacteriaceae in Korea between 2018 and 2019
Ahn Yeong-Seo

Bahk Hyun-Jung
Lee Yeon-Kyeng
Abstract
The aim of this article was to investigate CRE cases and outcomes in Korea between 2018 and 2019 to provide guidance to
the Korea Disease Control and Prevention Agency (KDCA) for future planning. The KDCA first conducted CRE surveillance in December 2010. The surveillance was monitored by only a small number of hospitals and then converted to mandatory
surveillance from June 3, 2017 by all medical institutions. This article investigated CRE cases as collected in the KDCA¡¯s
reporting system and found that 27,323 CRE cases were reported: 11,954 cases at 723 medical institutions in 2018 and
15,369 cases at 831 medical institutions in 2019. The cases were analyzed by year, species, age, and carbapenemaseproducing Enterobacteriaceae (CPE). Findings indicated that CRE increased from 11,954 in 2018 to 15,369 (25.8%) in 2019, with K. pneumoniae the most common of the CRE strains. In terms of types of hospitals, reports at long-term care hospitals increased from 4% (517 cases) in 2018 to 7% (1,077 cases) in 2019, and reports of CRE cases aged 70 or older accounted for the largest percentage. The CPE ratio among CRE cases increased from 49.8% in 2018 to 57.8% in 2019 (5,962 ¡æ 8,887 cases, 49.0% increase). To better assess and plan for the full burden of CRE, measures should be taken to prevent the spread of CRE.
KEYWORD
Cabapenem-resistant Enterobacteriaceae (CRE), Carbapenemase-producing Enterobacteriaceae (CPE)
FullTexts / Linksout information
Listed journal information